LifeMD Forecast, price target & analysts
LifeMD Target price 2026 - Analyst rating & recommendation
LifeMD Classifications & Recommendation
LifeMD Price Target
| Target Price | $7.65 |
| Price | $2.97 |
| Potential |
157.58%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target LifeMD 2027 .
The average LifeMD target price is $7.65.
This is
157.58%
register free of charge
$15.75
430.30%
register free of charge
$5.05
70.03%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend LifeMD to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the LifeMD stock has an average upside potential 2027 of
157.58%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 194.06 | 211.80 |
| 25.35% | 9.14% | |
| EBITDA Margin | -0.19% | -1.74% |
| 97.37% | 837.96% | |
| Net Margin | 5.80% | -11.94% |
| 136.60% | 305.96% |
10 Analysts have issued a sales forecast LifeMD 2026 . The average LifeMD sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an LifeMD EBITDA forecast 2026. The average LifeMD EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 LifeMD Analysts have issued a net profit forecast 2026. The average LifeMD net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.24 | -0.53 |
| 140.68% | 320.83% | |
| P/E | negative | |
| EV/Sales | 0.56 |
10 Analysts have issued a LifeMD forecast for earnings per share. The average LifeMD EPS is
This results in the following potential growth metrics and future valuations:
Current LifeMD Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 17 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Aug 06 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 26 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | May 04 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Mar 16 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 17 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 06 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 26 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
May 04 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Mar 16 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
